- Home
- CWCO vs RAPT Comparison
CWCO vs RAPT Comparison
Compare CWCO & RAPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CWCO | RAPT |
|---|---|---|
| Founded | 1973 | 2015 |
| Country | Cayman Islands | United States |
| Employees | N/A | N/A |
| Industry | Water Supply | Biotechnology: Pharmaceutical Preparations |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 599.8M | 498.4M |
| IPO Year | N/A | 2019 |
Fundamental Metrics
Financial Performance| Metric | CWCO | RAPT |
|---|---|---|
| Price | $37.01 | $57.66 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 10 |
| Target Price | $40.00 | ★ $56.22 |
| AVG Volume (30 Days) | 56.8K | ★ 2.1M |
| Earning Date | 03-16-2026 | 03-05-2026 |
| Dividend Yield | ★ 1.50% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.05 | N/A |
| Revenue | ★ $130,832,698.00 | N/A |
| Revenue This Year | $4.65 | N/A |
| Revenue Next Year | $52.38 | N/A |
| P/E Ratio | $34.50 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $22.69 | $5.67 |
| 52 Week High | $38.36 | $57.71 |
Technical Indicators
Market Signals| Indicator | CWCO | RAPT |
|---|---|---|
| Relative Strength Index (RSI) | 57.97 | 80.08 |
| Support Level | $35.69 | $32.00 |
| Resistance Level | $37.80 | $57.71 |
| Average True Range (ATR) | 0.90 | 1.63 |
| MACD | 0.09 | 2.90 |
| Stochastic Oscillator | 78.61 | 99.75 |
Price Performance
Historical ComparisonAbout CWCO Consolidated Water Co. Ltd.
Consolidated Water Co Ltd is a water utility company. It develops and operates seawater desalination plants and water distribution systems. The company's business segments are; The retail segment operates the water utility for the Seven Mile Beach and West Bay areas of Grand Cayman Island, The bulk segment supplies potable water to government utilities in Grand Cayman and The Bahamas under long-term contracts, The services segment designs, constructs and sells water infrastructure and provides management and operating services to third parties. The manufacturing segment manufactures and services a wide range of custom and specialized water-related products applicable to commercial, municipal, and industrial water production, supply, and treatment, and the corporate segment.
About RAPT RAPT Therapeutics Inc.
RAPT Therapeutics Inc is a clinical-stage immunology-based biopharmaceutical company. It is focused on discovering, developing, and commercializing oral small-molecule therapies for patients with some unmet needs in oncology and inflammatory diseases. The company pipeline products include FLX475, designed to selectively inhibit the migration of immunosuppressive regulatory T cells into tumors; and RPT193, designed to selectively inhibit the migration of type 2 T helper cells into inflamed tissues.